Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nabil Seery

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis and Related Disorders|September 21, 2020
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in AustraliaNabil Seery, Vivien Li, Ai-Lan Nguyen, et al.
BMJ Neurology Open|February 14, 2025
Monitoring the neurological complications of chimeric antigen receptor (CAR) T-cell therapy in patients with sensory and physical impairments and non-native-speaking backgrounds using modified immune effector cell-associated encephalopathy (ICE) scores: a case seriesChristina Kazzi, Ty Simpson, Cassandra Abbott, et al.
Journal of Neuroimmunology|August 14, 2025
Neurotoxicity associated with chimeric antigen receptor T-cell therapyMiriam Wronski, Robb Wesselingh, Christina Kazzi, et al.
CNS Drugs|April 13, 2021
Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort StudyNabil Seery, Sifat Sharmin, Vivien Li, et al.
Multiple Sclerosis and Related Disorders|December 3, 2023
Neutropaenia complications from Ocrelizumab and Rituximab treatmentVenus Pang, Nabil Seery, Robb Wesselingh, et al.
Journal of the Neurological Sciences|June 19, 2026
Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remissionMeltem Karadeniz, Robb Wesselingh, Padmakrishnan C Jayakrishnan, et al.
European Journal of Neurology|March 9, 2022
Diagnosis, differential diagnosis and misdiagnosis of Susac syndromeJames D Triplett, Jessica Qiu, Billy O'Brien, et al.
Clinical Immunology (Orlando, Fla.)|July 4, 2024
CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective studyMastura Monif, Richard P Sequeira, Andrea Muscat, et al.
British Journal of Haematology|July 28, 2025
CLOX and neurotox: Utility of the clock drawing task in monitoring for immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T-cell therapyChristina Kazzi, Ty Simpson, Miriam Wronski, et al.
Multiple Sclerosis and Related Disorders|March 15, 2026
Characterising executive functioning in the chronic phase of autoimmune encephalitis: A study by the Australian autoimmune encephalitis consortiumKatherine Y Ko, Nabil Seery, Sarah Griffith, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis and Related Disorders|September 21, 2020
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in AustraliaNabil Seery, Vivien Li, Ai-Lan Nguyen, et al.
BMJ Neurology Open|February 14, 2025
Monitoring the neurological complications of chimeric antigen receptor (CAR) T-cell therapy in patients with sensory and physical impairments and non-native-speaking backgrounds using modified immune effector cell-associated encephalopathy (ICE) scores: a case seriesChristina Kazzi, Ty Simpson, Cassandra Abbott, et al.
Journal of Neuroimmunology|August 14, 2025
Neurotoxicity associated with chimeric antigen receptor T-cell therapyMiriam Wronski, Robb Wesselingh, Christina Kazzi, et al.
CNS Drugs|April 13, 2021
Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort StudyNabil Seery, Sifat Sharmin, Vivien Li, et al.
Multiple Sclerosis and Related Disorders|December 3, 2023
Neutropaenia complications from Ocrelizumab and Rituximab treatmentVenus Pang, Nabil Seery, Robb Wesselingh, et al.
Journal of the Neurological Sciences|June 19, 2026
Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remissionMeltem Karadeniz, Robb Wesselingh, Padmakrishnan C Jayakrishnan, et al.
European Journal of Neurology|March 9, 2022
Diagnosis, differential diagnosis and misdiagnosis of Susac syndromeJames D Triplett, Jessica Qiu, Billy O'Brien, et al.
Clinical Immunology (Orlando, Fla.)|July 4, 2024
CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective studyMastura Monif, Richard P Sequeira, Andrea Muscat, et al.
British Journal of Haematology|July 28, 2025
CLOX and neurotox: Utility of the clock drawing task in monitoring for immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T-cell therapyChristina Kazzi, Ty Simpson, Miriam Wronski, et al.
Multiple Sclerosis and Related Disorders|March 15, 2026
Characterising executive functioning in the chronic phase of autoimmune encephalitis: A study by the Australian autoimmune encephalitis consortiumKatherine Y Ko, Nabil Seery, Sarah Griffith, et al.
Pageof 4